{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:28:35Z","timestamp":1772126915949,"version":"3.50.1"},"reference-count":90,"publisher":"American Society for Microbiology","issue":"13","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI127823"],"award-info":[{"award-number":["AI127823"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2020,6,16]]},"abstract":"<jats:p>Rabies PEP depends on anti-RABV IgG, which is expensive and in limited supply in geographical areas with the highest disease burden. Replacing the IgG component with a cost-effective and shelf-stable small-molecule antiviral could address this unmet clinical need by expanding access to life-saving medication. This study has established a robust protocol for high-throughput anti-RABV drug screens and identified a chemically well-behaved, first-in-class hit with nanomolar anti-RABV potency that blocks RABV G protein-mediated viral entry. Resistance mapping revealed a druggable site formed by the G protein fusion loops that has not previously emerged as a target for neutralizing antibodies. Discovery of this RABV entry inhibitor establishes a new molecular probe to advance further mechanistic and structural characterization of RABV G that may aid in the design of a next-generation clinical candidate against RABV.<\/jats:p>","DOI":"10.1128\/jvi.00321-20","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T15:07:03Z","timestamp":1587395223000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor"],"prefix":"10.1128","volume":"94","author":[{"given":"Venice","family":"Du Pont","sequence":"first","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Joong","family":"Yoon","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Cox","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9040-9405","authenticated-orcid":false,"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Plemper","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"885","volume-title":"Fields Virology","author":"Douglas S","year":"2013","unstructured":"Douglas S, Lyles IVK, Rupprecht CE. 2013. Rhabdoviridae, p 885\u2013922. In Knipe DM, Howley PM, Cohen JL, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields Virology, 6th ed, vol 1. Lippincott Williams and Wilkens, Philadelphia, PA.","edition":"6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.2017.1343516"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.06.061"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.014"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000497053"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.058"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0001-706x(98)00038-2"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.01.003"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1235"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.69.3.1444-1451.1995"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.7.3268-3276.2001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00084-06"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.06.084"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00289-07"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020069"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01425-13"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1405198111"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00898-16"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.14.96"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2016.02.002"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.09.020"},{"key":"e_1_3_2_23_2","first-page":"1","article-title":"Toward the development of a single-round infection assay based on EGFP reporting for anti-HIV-1 drug discovery","volume":"4","author":"Soezi M","year":"2015","unstructured":"Soezi M, Memarnejadian A, Aminzadeh S, Zabihollahi R, Sadat SM, Amini S, Hekmat S, Aghasadeghi MR. 2015. Toward the development of a single-round infection assay based on EGFP reporting for anti-HIV-1 drug discovery. Rep Biochem Mol Biol 4:1\u20139.","journal-title":"Rep Biochem Mol Biol"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2015.07.013"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042609"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/prot.340020406"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.6.3152"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2016.04.019"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297918010017"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000998"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7053569"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.9.7181-7190.1998"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.24.7250"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007189"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000149696"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.50.3.691-697.1984"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-65-4-781"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/13550280590900427"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.65.9.4853-4859.1991"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.67.3.1365-1372.1993"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005753"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)81072-7"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01870-09"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/108705719900400206"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00766-18"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-7534-3"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm5017768"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.04.014"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1127683"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01497-15"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718957115"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0602559"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2005.06.026"},{"key":"e_1_3_2_54_2","volume-title":"Assay guidance manual","author":"Strovel J","year":"2004","unstructured":"Strovel J, Sittampalam S, Coussens NP, Hughes M, Inglese J, Kurtz A, Andalibi A, Patton L, Austin C, Baltezor M, Beckloff M, Weingarten M, Weir S. 2004. Early drug discovery and development guidelines: for academic researchers, collaborators, and start-up companies. In Sittampalam GS, Grossman A, Brimacombe K, Arkin M, Auld D, Austin CP, Baell J, Bejcek B, Caaveiro JMM, Chung TDY, Coussens NP, Dahlin JL, Devanaryan V, Foley TL, Glicksman M, Hall MD, Haas JV, Hoare SRJ, Inglese J, Iversen PW, Kahl SD, Kales SC, Kirshner S, Lal-Nag M, Li Z, McGee J, McManus O, Riss T, Saradjian P, Trask OJ, Jr, Weidner JR, Wildey MJ, Xia M, Xu X (ed), Assay guidance manual. Eli Lilly and the National Center for Advancing Translational Sciences, Bethesda, MD."},{"key":"e_1_3_2_55_2","volume-title":"Assay guidance manual","author":"Iversen PW","year":"2004","unstructured":"Iversen PW, Beck B, Chen YF, Dere W, Devanarayan V, Eastwood BJ, Farmen MW, Iturria SJ, Montrose C, Moore RA, Weidner JR, Sittampalam GS. 2004. HTS assay validation. In Sittampalam GS, Gal-Edd N, Arkin M, Auld D, Austin C, Bejcek B, Glicksman M, Inglese J, Lemmon V, Li Z, McGee J, McManus O, Minor L, Napper A, Riss T, Trask OJ, Weidner J (ed), Assay guidance manual. Eli Lilly and the National Center for Advancing Translational Sciences, Bethesda, MD."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007038"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1936"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2020.02.007"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12030342"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm701284j"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.48.2.413-422.2004"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.9.5054-5064.2003"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2003.07.004"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308520101"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1166"},{"key":"e_1_3_2_66_2","first-page":"A4457","article-title":"A phase 2b, randomized, double-blind, placebo-controlled trial of presatovir (GS-5806), a novel oral RSV fusion inhibitor, for the treatment of respiratory syncytial virus (RSV) in hospitalized adults","volume":"197","author":"Hanfelt-Goade D","year":"2018","unstructured":"Hanfelt-Goade D, Maimon N, Nimer A, Riviere F, Catherinot E, Ison M, Jeong S, Walsh E, Gafter-Gvili A, Nama S, Napora P, Chowers M, Bergeron A, Zeltser D, Moudgil H, Limaye AP, Couturaud F, Nseir W, McKevitt M, Porter D, Jordan R, Guo Y, German P, Watkins TR, Gossage DL, Chien JW, Falsey AR. 2018. A phase 2b, randomized, double-blind, placebo-controlled trial of presatovir (GS-5806), a novel oral RSV fusion inhibitor, for the treatment of respiratory syncytial virus (RSV) in hospitalized adults. Am J Respir Crit Care Med 197:A4457.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1112"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00487-15"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00166a015"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M708955200"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1982"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.3.1524-1536.2006"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.7.4347-4356.2005"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252469399"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.69.9.5528-5534.1995"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.09.038"},{"key":"e_1_3_2_77_2","first-page":"393","article-title":"Generation of human ScFv antibodies for antigenic site III of rabies virus glycoprotein from antibody-phage libraries by chain shuffling","volume":"32","author":"Sun L","year":"2016","unstructured":"Sun L, Liu Y, Li C, Li D, Liang M. 2016. Generation of human ScFv antibodies for antigenic site III of rabies virus glycoprotein from antibody-phage libraries by chain shuffling. Bing Du Xue Bao 32:393\u2013398. (In Chinese.)","journal-title":"Bing Du Xue Bao"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.1.106-115.2005"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01688-17"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.011510698"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.5b00623"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-016-0137-3"},{"key":"e_1_3_2_84_2","first-page":"Unit 26.29","article-title":"Monitoring viral-mediated membrane fusion using fluorescent reporter methods","volume":"26","author":"Kondo N","year":"2011","unstructured":"Kondo N, Miyauchi K, Matsuda Z. 2011. Monitoring viral-mediated membrane fusion using fluorescent reporter methods. Curr Protoc Cell Biol Chapter 26:Unit 26.29.","journal-title":"Curr Protoc Cell Biol"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.26.14998"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1021\/ml200125r"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135710"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.65.8.4198-4203.1991"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(89)90122-0"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.62.1.1-7.1988"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.53.3.926-934.1985"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00321-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00321-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T15:00:29Z","timestamp":1646492429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.00321-20"}},"subtitle":[],"editor":[{"given":"Rebecca Ellis","family":"Dutch","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":90,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,6,16]]}},"alternative-id":["10.1128\/JVI.00321-20"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00321-20","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"2020-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00321-20"}}